TP53 and RB1 are predictive genetic biomarkers for sensitivity to cytarabine in gliomas Therapeutic progress in glioma, one of the most lethal human cancers, has been limited by molecular heterogeneity and lack of biomarker-driven drug deployment. Here we used a proprietary large-scale C...

📣 Excited to share our latest pre-print in precision medicine and molecular drug response stratification in brain tumours. [1/5] www.biorxiv.org/content/10.1...

#glioblastoma #GBM #biomarkerdiscovery #patientstratification #drugrepurposing